Concentra Group Holdings Parent, Inc.

NYSE:CON

Medical - Equipment & Services

Healthcare
$41.98 +0.53%

+$0.15 today

Market cap
$5.31B
Beta
0.82
P/E (TTM)
20.3
EPS (TTM)
$1.41
Dividend yield
0.88%
52W Low $18.55High $28.94

Volume 0.74M

Average 0.90M

CON Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Concentra Group Holdings Parent, Inc.NYSE: CON

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How CON compares with its peers on the latest reported figures

  • CON's LTM Sep 2026 research & development of $0 is the 8th highest of the 10 companies compared; the peer median is $59.46M.
  • Research & development amounts to 0.0% of revenue for CON, versus a peer median of 4.3%.
CON Competitors Peer median
Research & Development for CON and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$634M +1.3%+5.9%5.8%
BEAMBeam Therapeutics Inc.LTM Jun 2026$408.66M +3.1%+9.5%261.9%
HCMHUTCHMED (China) LimitedLTM Jun 2025$190.1M -25.1%-15.0%31.6%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$158M -0.6%-4.8%4.3%
HAEHaemonetics CorporationLTM Jun 2026$59.46M -4.4%+0.6%4.4%
ITGRInteger Holdings CorporationLTM Jul 2026$48.58M -4.7%-8.1%2.6%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$11.48M -17.7%-13.7%1.9%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$0 ——0.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$0 ——0.0%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding CON) $59.46M-4.4%-4.8%4.3%

Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.73B1.72B1.84B1.9B2.16B
Cost of Revenue1.3B1.32B1.33B1.37B1.55B
Gross Profit427.98M408.19M512.43M527.98M613.09M
Gross Margin24.7%23.7%27.9%27.8%28.3%
Research & Development00000
Selling, General & Admin157.71M149.98M152M156.32M203.31M
Operating Expenses157.71M149.98M224.8M223.21M279.1M
Depreciation & Amortization82.21M73.67M73.05M67.18M75.82M
EBITDA389.63M330.2M360.16M368.27M408.93M
EBITDA Margin22.5%19.1%19.6%19.4%18.9%
Operating Income270.27M258.22M287.63M304.76M333.99M
Operating Margin15.6%15.0%15.6%16.0%15.4%
Interest Income00000
Interest Expense31.86M31.64M114.04M69.69M109.29M
Other Income / Expenses5.3M(33.32M)(45M)(73.37M)(110.17M)
Income Before Tax275.56M224.9M242.63M231.39M223.83M
Pre-Tax Margin15.9%13.0%13.2%12.2%10.3%
Income Tax Expense59.53M52.65M57.89M59.5M50.98M
Net Income208.88M166.73M179.95M166.54M166.42M
Net Margin12.1%9.7%9.8%8.8%7.7%
EPS (Basic)1.651.321.421.301.39
EPS (Diluted)1.651.321.421.301.30
Weighted Avg Shares126.59M126.59M126.59M128.13M126.65M
Weighted Avg Shares (Diluted)126.59M126.59M126.59M128.13M128.17M

Concentra Group Holdings Parent, Inc.

NYSE:CON

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.